Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Rebecca Aubrey Betensky, Ph.D.

Co-Author

This page shows the publications co-authored by Rebecca Betensky and David Louis.
Connection Strength

2.203
  1. Statistical considerations for immunohistochemistry panel development after gene expression profiling of human cancers. J Mol Diagn. 2005 May; 7(2):276-82.
    View in: PubMed
    Score: 0.316
  2. Genome-wide comparison of paired fresh frozen and formalin-fixed paraffin-embedded gliomas by custom BAC and oligonucleotide array comparative genomic hybridization: facilitating analysis of archival gliomas. Acta Neuropathol. 2011 Apr; 121(4):529-43.
    View in: PubMed
    Score: 0.116
  3. A latent class model with hidden Markov dependence for array CGH data. Biometrics. 2009 Dec; 65(4):1296-305.
    View in: PubMed
    Score: 0.109
  4. Bone involvement predicts poor outcome in atypical meningioma. J Neurosurg. 2009 Sep; 111(3):464-71.
    View in: PubMed
    Score: 0.107
  5. Application of signal processing techniques for estimating regions of copy number variations in human meningioma DNA. Annu Int Conf IEEE Eng Med Biol Soc. 2009; 2009:6973-6.
    View in: PubMed
    Score: 0.102
  6. Tests of association under misclassification: application to histological sampling in oncology. Stat Med. 2007 Nov 20; 26(26):4808-16.
    View in: PubMed
    Score: 0.094
  7. Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment. Clin Cancer Res. 2007 Apr 01; 13(7):2038-45.
    View in: PubMed
    Score: 0.090
  8. Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2. J Neuropathol Exp Neurol. 2006 Dec; 65(12):1149-56.
    View in: PubMed
    Score: 0.088
  9. AKT activation in human glioblastomas enhances proliferation via TSC2 and S6 kinase signaling. Cancer Res. 2006 Jun 01; 66(11):5618-23.
    View in: PubMed
    Score: 0.085
  10. Glioma test array for use with formalin-fixed, paraffin-embedded tissue: array comparative genomic hybridization correlates with loss of heterozygosity and fluorescence in situ hybridization. J Mol Diagn. 2006 May; 8(2):268-76.
    View in: PubMed
    Score: 0.085
  11. A pseudolikelihood approach for simultaneous analysis of array comparative genomic hybridizations. Biostatistics. 2006 Jul; 7(3):399-421.
    View in: PubMed
    Score: 0.083
  12. In situ analysis of integrin and growth factor receptor signaling pathways in human glioblastomas suggests overlapping relationships with focal adhesion kinase activation. Am J Pathol. 2005 Nov; 167(5):1379-87.
    View in: PubMed
    Score: 0.082
  13. Histology-based expression profiling yields novel prognostic markers in human glioblastoma. J Neuropathol Exp Neurol. 2005 Nov; 64(11):948-55.
    View in: PubMed
    Score: 0.082
  14. Age-dependent prognostic effects of genetic alterations in glioblastoma. Clin Cancer Res. 2004 Jan 01; 10(1 Pt 1):228-33.
    View in: PubMed
    Score: 0.072
  15. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res. 2003 Apr 01; 63(7):1602-7.
    View in: PubMed
    Score: 0.068
  16. Analysis of a molecular genetic neuro-oncology study with partially biased selection. Biostatistics. 2003 Apr; 4(2):167-78.
    View in: PubMed
    Score: 0.068
  17. Influence of unrecognized molecular heterogeneity on randomized clinical trials. J Clin Oncol. 2002 May 15; 20(10):2495-9.
    View in: PubMed
    Score: 0.064
  18. DMBT1 polymorphisms: relationship to malignant glioma tumorigenesis. Cancer Res. 2002 Mar 15; 62(6):1790-6.
    View in: PubMed
    Score: 0.064
  19. Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma". J Neuropathol Exp Neurol. 2002 Jan; 61(1):58-63.
    View in: PubMed
    Score: 0.063
  20. PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis. Am J Pathol. 2001 Jul; 159(1):359-67.
    View in: PubMed
    Score: 0.061
  21. Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin Cancer Res. 2001 Apr; 7(4):839-45.
    View in: PubMed
    Score: 0.060
  22. Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. Cancer Cell. 2011 Dec 13; 20(6):810-7.
    View in: PubMed
    Score: 0.031
  23. Assessing Population Level Genetic Instability via Moving Average. Stat Biosci. 2010 Dec; 2(2):120-136.
    View in: PubMed
    Score: 0.029
  24. Polysomy for chromosomes 1 and 19 predicts earlier recurrence in anaplastic oligodendrogliomas with concurrent 1p/19q loss. Clin Cancer Res. 2009 Oct 15; 15(20):6430-7.
    View in: PubMed
    Score: 0.027
  25. Genomic profiling of atypical meningiomas associates gain of 1q with poor clinical outcome. J Neuropathol Exp Neurol. 2009 Oct; 68(10):1155-65.
    View in: PubMed
    Score: 0.027
  26. Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival. J Neuropathol Exp Neurol. 2006 Dec; 65(12):1181-8.
    View in: PubMed
    Score: 0.022
  27. Genetic analyses for predictors of radiation response in glioblastoma. Int J Radiat Oncol Biol Phys. 2005 Nov 01; 63(3):704-10.
    View in: PubMed
    Score: 0.020
  28. YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas. Clin Cancer Res. 2005 Mar 15; 11(6):2258-64.
    View in: PubMed
    Score: 0.020
  29. Imaging correlates of molecular signatures in oligodendrogliomas. Clin Cancer Res. 2004 Jul 01; 10(13):4303-6.
    View in: PubMed
    Score: 0.019
  30. BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma. Clin Cancer Res. 2003 Mar; 9(3):1063-9.
    View in: PubMed
    Score: 0.017
  31. The use of frailty hazard models for unrecognized heterogeneity that interacts with treatment: considerations of efficiency and power. Biometrics. 2002 Mar; 58(1):232-6.
    View in: PubMed
    Score: 0.016
  32. Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Res. 2001 Sep 15; 61(18):6713-5.
    View in: PubMed
    Score: 0.015
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.